Targeting drug efflux pumps like ABC transporters (PGP, BCRP, MRP1, and MRP2) would increase the intracellular concentration of chemotherapy drugs, thereby improving their effectiveness in tumor cells. This evidence concerns the gene ABCG2 and neoplasm.